Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin

Journal of Clinical Investigation

Volumn 118, Issue 6, 2008, Pages 2098-2110

  Sancho, David ^a   Mourão Sá, Diego ^a   Joffre, Olivier P ^a   Schulz, Oliver ^a   Rogers, Neil C ^a   Pennington, Daniel J ^b   Carlyle, James R ^c   Sousa, Caetano Reis ^a,d  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c Sunnybrook Health Sciences Centre   (Canada)

^d THE FRANCIS CRICK INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN; LECTIN RECEPTOR; NATURAL KILLER LECTIN GROUP RECEPTOR 1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; DENDRITIC CELL; ENDOCYTOSIS; HEMATOPOIETIC CELL; LUNG METASTASIS; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIGENS; ANTIGENS, CD8; DENDRITIC CELLS; HUMANS; IMMUNOTHERAPY; LECTINS; LUNG NEOPLASMS; MELANOMA; MICE; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES, CYTOTOXIC;

EID: 45749112103     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI34584     Document Type: Article

References (63)

1. Steinman, R. 2007. Dendritic cells: versatile controllers of the immune system. Nat. Med. 13:1155-1159.
2. Villadangos, J., and Schnorrer, P. 2007. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 7:543-555.
3. Vremec, D., and Shortman, K. 1997. Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. J. Immunol. 159:565-573.
4. Henri, S., et al. 2001. The dendritic cell populations of mouse lymph nodes. J. Immunol. 167:741-748.
5. den Haan, J.M., Lehar, S.M., and Bevan, M.J. 2000. CD8(+) but Not CD8(-) Dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192:1685-1696.
6. Valdez, Y., et al. 2002. Major histocompatibility complex class II presentation of cell- associated antigen is mediated by CD8alpha+ dendritic cells in vivo. J. Exp. Med. 195:683-694.
7. Belz, G.T., et al. 2002. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J. Exp. Med. 196:1099-1104.
8. Scheinecker, C., McHugh, R., Shevach, E.M., and Germain, R.N. 2002. Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node. J. Exp. Med. 196:1079-1090.
9. Schulz, O., and Reis e Sousa, C. 2002. Cross-presentation of cell-associated antigens by CD8alpha+ dendritic cells is attributable to their ability to internalize dead cells. Immunology. 107:183-189.
10. Iyoda, T., et al. 2002. The CD8(+) Dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195:1289-1302.
11. Schnorrer, P., et al. 2006. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc. Natl. Acad. Sci. U. S. A. 103:10729-10734.
12. Carter, R.W., Thompson, C., Reid, D.M., Wong, S.Y., and Tough, D.F. 2006. Preferential induction of CD4+ T cell responses through in vivo targeting of antigen to dendritic cell-associated C-type lectin-1. J. Immunol. 177:2276-2284.
13. Dudziak, D., et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science. 315:107-111.
14. Allan, R.S., et al. 2003. Epidermal viral immunity induced by CD8alpha+ dendritic cells but not by Langerhans cells. Science. 301:1925-1928.
15. Belz, G.T., et al. 2004. Cutting edge: conventional CD8alpha(+) dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 172:1996-2000.
16. Belz, G.T., et al. 2004. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. U. S. A. 101:8670-8675.
17. Belz, G.T., Shortman, K., Bevan, M.J., and Heath, W.R. 2005. CD8alpha+ dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens in vivo. J. Immunol. 175:196-200.
18. Allan, R.S., et al. 2006. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity. 25:153-162.
19. Wilson, N., et al. 2006. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7:165-172.
20. Edwards, A., et al. 2003. Relationships among murine CD11c(high) dendritic cell subsets as revealed by baseline gene expression patterns. J. Immunol. 171:47-60.
21. Tacken, P., de Vries, I., Torensma, R., and Figdor, C. 2007. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 7:790-802.
22. Steinman, R., and Banchereau, J. 2007. Taking dendritic cells into medicine. Nature. 449:419-426.
23. Hawiger, D., et al. 2001. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769-779.
24. Bonifaz, L., et al. 2002. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196:1627-1638.
25. Bonifaz, L.C., et al. 2004. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199:815-824.
26. Mahnke, K., et al. 2005. Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice. Cancer Res. 65:7007-7012.
27. Trumpfheller, C., et al. 2006. Intensified and protective CD4+ T cell immunity in mice with antidendritic cell HIV gag fusion antibody vaccine. J. Exp. Med. 203:607-617.
28. Boscardin, S., et al. 2006. Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses. J. Exp. Med. 203:599-606.
29. Soares, H., et al. 2007. A subset of dendritic cells induces CD4+ T cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo. J. Exp. Med. 204:1095-1106.
30. Mahnke, K., Qian, Y., Knop, J., and Enk, A.H. 2003. Induction of CD4+/CD25+ regulatory T cells by targeting of antigens to immature dendritic cells. Blood. 101:4862-4869.
31. Hawiger, D., Masilamani, R., Bettelli, E., Kuchroo, V., and Nussenzweig, M. 2004. Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity. 20:695-705.
32. Kretschmer, K., et al. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6:1219-1227.
33. Tacken, P.J., Torensma, R., and Figdor, C.G. 2006. Targeting antigens to dendritic cells in vivo. Immunobiology. 211:599-608.
34. Figdor, C., van Kooyk, Y., and Adema, G. 2002. C-type lectin receptors on dendritic cells and Langerhans cells. Nat. Rev. Immunol. 2:77-84.
35. Robinson, M., et al. 2006. Myeloid C-type lectins in innate immunity. Nat. Immunol. 7:1258-1265.
36. Carter, R., Thompson, C., Reid, D., Wong, S., and Tough, D. 2006. Induction of CD8+ T cell responses through targeting of antigen to Dectin-2. Cell. Immunol. 239:87-91.
37. Corbett, A.J., et al. 2005. Antigen delivery via two molecules on the CD8- dendritic cell subset induces humoral immunity in the absence of conventional "danger". Eur. J. Immunol. 35:2815-2825.
38. Jiang, W., et al. 1995. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature. 375:151-155.
39. Mahnke, K., et al. 2000. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151:673-684.
40. Kraal, G., Breel, M., Janse, M., and Bruin, G. 1986. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J. Exp. Med. 163:981-997.
41. Inaba, K., et al. 1995. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes. Cell. Immunol. 163:148-156.
42. Witmer-Pack, M.D., Swiggard, W.J., Mirza, A., Inaba, K., and Steinman, R.M. 1995. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. II. Expression in situ in lymphoid and nonlymphoid tissues. Cell. Immunol. 163:157-162.
43. Kato, M., et al. 2006. Expression of human DEC-205 (CD205) multilectin receptor on leukocytes. Int. Immunol. 18:857-869.
44. Hao, L., Klein, J., and Nei, M. 2006. Heterogeneous but conserved natural killer receptor gene complexes in four major orders of mammals. Proc. Natl. Acad. Sci. U. S. A. 103:3192-3197.
45. Drickamer, K. 1999. C-type lectin-like domains. Curr. Opin. Struct. Biol. 9:585-590.
46. Naik, S.H., et al. 2005. Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures. J. Immunol. 174:6592-6597.
47. Overwijk, W.W., et al. 1998. gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J. Exp. Med. 188:277-286.
48. Dyall, R., et al. 1998. Heteroclitic immunization induces tumor immunity. J. Exp. Med. 188:1553-1561.
49. Bloom, M.B., et al. 1997. Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma. J. Exp. Med. 185:453-459.
50. MacDonald, K.P., et al. 2002. Characterization of human blood dendritic cell subsets. Blood. 100:4512-4520.
51. Dzionek, A., et al. 2000. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165:6037-6046.
52. Narbutt, J., et al. 2004. The distribution of peripheral blood dendritic cells assayed by a new panel of anti-BDCA monoclonal antibodies in healthy representatives of the polish population. Cell. Mol. Biol. Lett. 9:497-509.
53. Galibert, L., et al. 2005. Nectin-like protein 2 defines a subset of T-cell zone dendritic cells and is a ligand for class-I-restricted T-cell-associated molecule. J. Biol. Chem. 280:21955-21964.
54. Lindstedt, M., Lundberg, K., and Borrebaeck, C. 2005. Gene family clustering identifies functionally associated subsets of human in vivo blood and tonsillar dendritic cells. J. Immunol. 175:4839-4846.
55. Robbins, S.H., et al. 2008. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 9:R17.
56. Salio, M., Palmowski, M.J., Atzberger, A., Hermans, I.F., and Cerundolo, V. 2004. CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. J. Exp. Med. 199:567-579.
57. Burgdorf, S., Kautz, A., Böhnert, V., Knolle, P., and Kurts, C. 2007. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science. 316:612-616.
58. Rogers, N.C., et al. 2005. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity. 22:507-517.
59. Leibundgut-Landmann, S., et al. 2007. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8:630-638.
60. Karttunen, J., Sanderson, S., and Shastri, N. 1992. Detection of rare antigen-presenting cells by the lacZ T-cell activation assay suggests an expression cloning strategy for T-cell antigens. Proc. Natl. Acad. Sci. U. S. A. 89:6020-6024.
61. Mesci, A., and Carlyle, J. 2007. A rapid and efficient method for the generation and screening of monoclonal antibodies specific for cell surface antigens. J. Immunol. Methods. 323:78-87.
62. Schulz, O., et al. 2005. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature. 433:887-892.
63. Hermans, I.F., et al. 2004. The VITAL assay: a versatile fluorometric technique for assessing CTL-and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J. Immunol. Methods. 285:25-40.